Manulife (Manufacturers Life Insurance)’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $211K | Buy |
+10,316
| New | +$211K | ﹤0.01% | 2536 |
|
|
2025
Q1 | – | Sell |
-9,467
| Closed | -$252K | – | 2912 |
|
|
2024
Q4 | $252K | Sell |
9,467
-453
| -5% | -$12.1K | ﹤0.01% | 2530 |
|
|
2024
Q3 | $283K | Sell |
9,920
-202
| -2% | -$5.76K | ﹤0.01% | 2498 |
|
|
2024
Q2 | $220K | Buy |
10,122
+675
| +7% | +$14.7K | ﹤0.01% | 2564 |
|
|
2024
Q1 | $209K | Sell |
9,447
-503
| -5% | -$11.1K | ﹤0.01% | 2577 |
|
|
2023
Q4 | $215K | Sell |
9,950
-395
| -4% | -$8.52K | ﹤0.01% | 2595 |
|
|
2023
Q3 | $175K | Hold |
10,345
| – | – | ﹤0.01% | 2654 |
|
|
2023
Q2 | $142K | Buy |
10,345
+711
| +7% | +$9.76K | ﹤0.01% | 2728 |
|
|
2023
Q1 | $219K | Hold |
9,634
| – | – | ﹤0.01% | 2498 |
|
|
2022
Q4 | $227K | Buy |
9,634
+139
| +1% | +$3.27K | ﹤0.01% | 2487 |
|
|
2022
Q3 | $248K | Sell |
9,495
-244
| -3% | -$6.36K | ﹤0.01% | 2431 |
|
|
2022
Q2 | $214K | Buy |
9,739
+1,069
| +12% | +$23.5K | ﹤0.01% | 2628 |
|
|
2022
Q1 | $389K | Sell |
8,670
-2,263
| -21% | -$102K | ﹤0.01% | 2350 |
|
|
2021
Q4 | $469 | Buy |
10,933
+208
| +2% | +$9 | ﹤0.01% | 2303 |
|
|
2021
Q3 | $713K | Sell |
10,725
-1,234
| -10% | -$82K | ﹤0.01% | 2043 |
|
|
2021
Q2 | $877K | Buy |
11,959
+3,777
| +46% | +$277K | ﹤0.01% | 2072 |
|
|
2021
Q1 | $560K | Buy |
8,182
+957
| +13% | +$65.5K | ﹤0.01% | 2203 |
|
|
2020
Q4 | $485K | Buy |
7,225
+522
| +8% | +$35K | ﹤0.01% | 2215 |
|
|
2020
Q3 | $345K | Buy |
6,703
+396
| +6% | +$20.4K | ﹤0.01% | 2196 |
|
|
2020
Q2 | $228K | Buy |
+6,307
| New | +$228K | ﹤0.01% | 2430 |
|